These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 18982820

  • 1. Is asymptomatic peripheral neuropathy present in Nigerian diabetic patients? An assessment using the United Kingdom screening test (UKST) and bio-thesiometry.
    Oguejiofor OC, Oli JM, Ajaero CN, Odenigbo CU, Odike MA.
    Afr J Med Med Sci; 2008 Sep; 37(3):265-71. PubMed ID: 18982820
    [Abstract] [Full Text] [Related]

  • 2. Are the symptoms of diabetic peripheral neuropathy in Nigerian patients objective? An evaluation using the United Kingdom Screening Test (UKST) and Bio-Thesiometry.
    Oguejiofor OC, Oli JM, Ajaero CN, Odenigbo CU, Odike MA.
    Niger J Clin Pract; 2009 Jun; 12(2):113-9. PubMed ID: 19764655
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
    Oguejiofor OC, Odenigbo CU, Oguejiofor CB.
    Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
    Kamenov ZA, Petrova JJ, Christov VG.
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
    [Abstract] [Full Text] [Related]

  • 5. [Foot disease in Icelandic patients with established type 2 diabetes].
    Heimisdottir F, Gudnason V, Sigurdsson G, Benediktsson R.
    Laeknabladid; 2008 Feb; 94(2):109-14. PubMed ID: 18310775
    [Abstract] [Full Text] [Related]

  • 6. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy.
    Moghtaderi A, Bakhshipour A, Rashidi H.
    Clin Neurol Neurosurg; 2006 Jul; 108(5):477-81. PubMed ID: 16150538
    [Abstract] [Full Text] [Related]

  • 7. [Measurement of vibratory threshold in the diagnosis of diabetic neuropathy].
    Ribera RL, Valls J, González-Clemente JM, Vidal J, Manzanares JM, Esmatjes E.
    Rev Clin Esp; 1994 Oct; 194(10):901-5. PubMed ID: 7800871
    [Abstract] [Full Text] [Related]

  • 8. Association between asymptomatic median mononeuropathy and diabetic polyneuropathy severity in patients with diabetes mellitus.
    Stamboulis E, Voumvourakis K, Andrikopoulou A, Koutsis G, Tentolouris N, Kodounis A, Tsivgoulis G.
    J Neurol Sci; 2009 Mar 15; 278(1-2):41-3. PubMed ID: 19059612
    [Abstract] [Full Text] [Related]

  • 9. Reproducibility of vibratory perception thresholds in patients with diabetic neuropathy.
    Bertelsmann FW, Heimans JJ, van Rooy JC, Heine RJ, van der Veen EA.
    Diabetes Res; 1986 Nov 15; 3(9):463-6. PubMed ID: 3829585
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N, Yamane K, Nakanishi S, Yamashita Y, Tamura T, Ohshita K, Watanabe H, Fujikawa R, Okubo M, Kohno N.
    J Diabetes Complications; 2005 Nov 15; 19(1):47-53. PubMed ID: 15642490
    [Abstract] [Full Text] [Related]

  • 11. Assessment of sensory neuropathy in diabetic patients without diabetic foot problems.
    Nather A, Neo SH, Chionh SB, Liew SC, Sim EY, Chew JL.
    J Diabetes Complications; 2008 Nov 15; 22(2):126-31. PubMed ID: 18280443
    [Abstract] [Full Text] [Related]

  • 12. [Non-invasive diagnosis of angiopathies and neuropathies in screening for the diabetic foot syndrome].
    Jirkovská A, Wosková V, Bartos V, Skibová J.
    Vnitr Lek; 1998 May 15; 44(5):269-73. PubMed ID: 9820070
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects.
    Kästenbauer T, Irsigler P, Sauseng S, Grimm A, Prager R.
    J Diabetes Complications; 2004 May 15; 18(1):27-31. PubMed ID: 15019596
    [Abstract] [Full Text] [Related]

  • 14. Validity of the Diabetic Neuropathy Score and Diabetic Neuropathy Examination score as screening tools for the detection of distal symmetrical diabetic neuropathy.
    Liyanage PL, Lekamwasam S, Weerarathna TP.
    J Diabetes; 2012 Sep 15; 4(3):264-5. PubMed ID: 22507170
    [No Abstract] [Full Text] [Related]

  • 15. Pupillography refines the diagnosis of diabetic autonomic neuropathy.
    Dütsch M, Marthol H, Michelson G, Neundörfer B, Hilz MJ.
    J Neurol Sci; 2004 Jul 15; 222(1-2):75-81. PubMed ID: 15240199
    [Abstract] [Full Text] [Related]

  • 16. The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds.
    Coppini DV, Wellmer A, Weng C, Young PJ, Anand P, Sönksen PH.
    J Clin Neurosci; 2001 Nov 15; 8(6):520-4. PubMed ID: 11683597
    [Abstract] [Full Text] [Related]

  • 17. Quantitative measurement of cutaneous perception in diabetic neuropathy.
    Vinik AI, Suwanwalaikorn S, Stansberry KB, Holland MT, McNitt PM, Colen LE.
    Muscle Nerve; 1995 Jun 15; 18(6):574-84. PubMed ID: 7753119
    [Abstract] [Full Text] [Related]

  • 18. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients.
    Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi JM, Said G.
    J Neurol; 2002 May 15; 249(5):569-75. PubMed ID: 12021947
    [Abstract] [Full Text] [Related]

  • 19. [Screening for peripheral neuropathy: which tools?].
    Gin H, Rigalleau V.
    Diabetes Metab; 2002 Jun 15; 28(3):250-4. PubMed ID: 12149608
    [Abstract] [Full Text] [Related]

  • 20. Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level.
    Azzopardi K, Gatt A, Chockalingam N, Formosa C.
    Prim Care Diabetes; 2018 Apr 15; 12(2):111-115. PubMed ID: 29029862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.